Light has always carried more than brightness. In this case, it also carries direction and twist. That mix may open a new ...

Momentum is building in Broad Ripple to find ways to move the village forward and adjust to the changing demographics and ...

In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines. Providing clarity around modern ...

Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...

A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...

Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026A ...

Drugmakers continue to test weight-loss medicines against dummy pills and shots, even with a growing number of effective approved obesity drugs. This practice raises practical questions.

"Rethink, modify, redo" is not a crisis response. It's a way of operating that allows businesses to adapt without losing ...

This valuable study addressed a key question in epilepsy research: whether the recordings of very fast oscillations in the brain (>250Hz, fast ripples) reflect underlying pathology or might be a ...

In a complex therapeutic landscape, WuXi AppTec is simplifying the path from discovery to patient. Find out how.

A new scenario for superconductivity is revealed, whereby applying pressure to the Kondo ferromagnet Ce5CoGe2 first induces a ...

Uniform, globally accepted greenness metrics are positioned as essential; inconsistent scoring frameworks would erode ...